Sensex Rises Over 100 Points, Nifty Above 10,850; IT, Pharma Stocks Lead Gains
The domestic equity markets traded firmly in the green on Wednesday. At 9:40 am, the S&P BSE Sensex was at 35,802.15 level, up 109.63 points or 0.31 per cent, and the broader Nifty50 was at 10,871.80, with a gain of 28.95 points or 0.27 per cent. IT and pharma stocks led the gains. The top gainers in the 30-share Sensex pack were Sun Pharma (up 2.43 per cent), Dr Reddy's Laboratories (up 1.94 per cent), Tata Consultancy Services (up 1.52 per cent), Axis Bank (up 1.84 per cent) and State Bank of India (up 1.10 per cent). On the NSE's sectoral indices, nine out of 10 IT stocks and eight out of 10 pharma advanced in trade.
In terms of stock-specific action, Sun Pharma gained after the company said that it has received approval for its Halol facility from the USFDA (Food and Drug Administration).
On Tuesday, retail inflation rose to a four-month high of 4.87 per cent in May as compared to 4.58 per cent last month. Industrial growth registered a rise of 4.9 per cent in April from a year earlier.
Meanwhile, global investors looked for cues on future interest rate hikes from the US Federal Reserve meet, which will be over on June 13. The Fed is widely expected to raise interest rates for the second time this year after a move in March, but the bigger question for investors is the outlook for future monetary tightening amid an ongoing economic expansion.
MSCI's broadest index of Asia-Pacific shares outside Japan dipped 0.15 per cent in early trade and Japan's Nikkei eked out gains of 0.25 per cent, following the 0.17 per cent gains in the US S&P 500 the previous day.
On Tuesday, foreign portfolio investors net sold equities worth Rs 1,168.88 crore while domestic institutional investors net purchased shares worth Rs 1,327.45 crore, according to provisional data from the National Stock Exchange (NSE). (With Reuters Inputs)
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
